{
  "trial_id": "NCT02279394",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, ECOG Performance Status, Serum M protein level, Bone marrow plasma cell percentage, Serum involved/uninvolved free light chain ratio, Presence of t(4;14) or del 17p or 1q gain, Presence of MRI or PET-CT abnormalities, ANC, Platelet count, Total bilirubin, AST, ALT, Estimated creatinine clearance, Pregnancy test status (for females of childbearing potential), Prior therapy for smoldering myeloma, History of allergic reactions, Viral infection status (HIV, hepatitis B, hepatitis C).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Pregnancy test status (for females of childbearing potential)"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Gender",
        "Serum M protein level",
        "Bone marrow plasma cell percentage",
        "Serum involved/uninvolved free light chain ratio",
        "Presence of t(4;14) or del 17p or 1q gain",
        "Presence of MRI or PET-CT abnormalities",
        "ANC",
        "Platelet count",
        "Total bilirubin",
        "AST",
        "ALT",
        "Estimated creatinine clearance",
        "Prior therapy for smoldering myeloma",
        "History of allergic reactions",
        "Viral infection status (HIV, hepatitis B, hepatitis C)"
      ]
    },
    "processed-gen-response": "Age, Gender, ECOG Performance Status, Serum M protein level, Bone marrow plasma cell percentage, Serum involved/uninvolved free light chain ratio, Presence of t(4;14) or del 17p or 1q gain, Presence of MRI or PET-CT abnormalities, ANC, Platelet count, Total bilirubin, AST, ALT, Estimated creatinine clearance, Pregnancy test status (for females of childbearing potential), Prior therapy for smoldering myeloma, History of allergic reactions, Viral infection status (HIV, hepatitis B, hepatitis C)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Bone Marrow Plasma Cells Percentage, Serum M Protein Level, Immunoglobulin Levels, Serum Free Light Chain Ratio, MRI Findings, PET-CT Findings, Hemoglobin Level, Serum Calcium Level, Creatinine Clearance, Total Bilirubin, AST, ALT, Platelet Count, ANC",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Bone Marrow Plasma Cells Percentage",
        "Serum M Protein Level",
        "Immunoglobulin Levels",
        "Serum Free Light Chain Ratio",
        "MRI Findings",
        "PET-CT Findings",
        "Hemoglobin Level",
        "Serum Calcium Level",
        "Creatinine Clearance",
        "Total Bilirubin",
        "AST",
        "ALT",
        "Platelet Count",
        "ANC"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Bone Marrow Plasma Cells Percentage, Serum M Protein Level, Immunoglobulin Levels, Serum Free Light Chain Ratio, MRI Findings, PET-CT Findings, Hemoglobin Level, Serum Calcium Level, Creatinine Clearance, Total Bilirubin, AST, ALT, Platelet Count, ANC"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Bone Marrow Plasma Cells, Serum M Protein, IgA SMM, Immunoparesis, Serum Involved/Uninvolved Free Light Chain Ratio, Bone Marrow Clonal Plasma Cells, Abnormal Plasma Cell Immunophenotype, t(4;14) or del 17p or 1q gain, Increased Circulating Plasma Cells, MRI with Diffuse Abnormalities or 1 Focal Lesion, PET-CT with Focal Lesion with Increased Uptake, ANC, PLT, Total Bilirubin, AST, ALT, Estimated Creatinine Clearance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Bone Marrow Plasma Cells",
        "Serum M Protein",
        "IgA SMM",
        "Immunoparesis",
        "Serum Involved/Uninvolved Free Light Chain Ratio",
        "Bone Marrow Clonal Plasma Cells",
        "Abnormal Plasma Cell Immunophenotype",
        "t(4;14) or del 17p or 1q gain",
        "Increased Circulating Plasma Cells",
        "MRI with Diffuse Abnormalities or 1 Focal Lesion",
        "PET-CT with Focal Lesion with Increased Uptake",
        "ANC",
        "PLT",
        "Total Bilirubin",
        "AST",
        "ALT",
        "Estimated Creatinine Clearance"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Bone Marrow Plasma Cells, Serum M Protein, IgA SMM, Immunoparesis, Serum Involved/Uninvolved Free Light Chain Ratio, Bone Marrow Clonal Plasma Cells, Abnormal Plasma Cell Immunophenotype, t(4;14) or del 17p or 1q gain, Increased Circulating Plasma Cells, MRI with Diffuse Abnormalities or 1 Focal Lesion, PET-CT with Focal Lesion with Increased Uptake, ANC, PLT, Total Bilirubin, AST, ALT, Estimated Creatinine Clearance."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG Performance Status, body mass index, smoking status, medical history (including prior therapies and comorbidities), laboratory values (including ANC, PLT, total bilirubin, AST, ALT, estimated creatinine clearance), Mayo or Spanish criteria for high-risk smoldering multiple myeloma, serum M protein level, IgA SMM status, immunoparesis status, serum involved/uninvolved free light chain ratio, bone marrow clonal plasma cells percentage, abnormal plasma cell immunophenotype, t(4;14) or del 17p or 1q gain status, circulating plasma cells level, MRI or PET-CT findings.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index",
        "smoking status",
        "medical history (including prior therapies and comorbidities)",
        "laboratory values (including ANC, PLT, total bilirubin, AST, ALT, estimated creatinine clearance)",
        "Mayo or Spanish criteria for high-risk smoldering multiple myeloma",
        "serum M protein level",
        "IgA SMM status",
        "immunoparesis status",
        "serum involved/uninvolved free light chain ratio",
        "bone marrow clonal plasma cells percentage",
        "abnormal plasma cell immunophenotype",
        "t(4;14) or del 17p or 1q gain status",
        "circulating plasma cells level",
        "MRI or PET-CT findings."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG Performance Status, body mass index, smoking status, medical history (including prior therapies and comorbidities), laboratory values (including ANC, PLT, total bilirubin, AST, ALT, estimated creatinine clearance), Mayo or Spanish criteria for high-risk smoldering multiple myeloma, serum M protein level, IgA SMM status, immunoparesis status, serum involved/uninvolved free light chain ratio, bone marrow clonal plasma cells percentage, abnormal plasma cell immunophenotype, t(4;14) or del 17p or 1q gain status, circulating plasma cells level, MRI or PET-CT findings."
  }
}